menu
menu
arrow
hexagon-play-button
Take the tour
CERIC
Open Access
Offer
hexagon-arrow

Open for
Scientific Users

CERIC offers a free, multidisciplinary open access service for users selected on quality by international competition, offering complementary analytical and modification techniques for nano-level science and technology.

> Learn more

Open for
Industry

CERIC is an innovation ecosystem for industry, offering services and technologies, technical and scientific knowledge and skills, and strong industry expertise, with a strategic outlook in nanotech.

> Learn more

Open for
Media & Public

CERIC is a trading post for Research, Education and Industry, driving innovation in Europe, and responding to multiple challenges by attracting the best capabilities at world level.

> Learn more

Featured

Latest

When our users get to our partner facilities, CommsOffice hunts for interviews

Follow the link for our new interview with Lorenzo Stievano (@loroik), Romain Wernert (@RomainWernert) and Valentin Saibi on their research on new generation #batteries

🎥https://bit.ly/3IxOk1W

.@ESFRI_eu has welcomed 11 new research infrastructure projects to its 2021 Roadmap, at a cost of €4.16B. This will require investments in synergy across different funds, such as national & cohesion funds, recovery and resilience facility, and Horizon EU.
https://bit.ly/3y8hC2p

About Us

CERIC-ERIC is a multidisciplinary Research Infrastructure open for basic and applied users in the fields of Materials, Biomaterials and Nanotechnology. With a single entry point to excellent facilities in Central and Eastern Europe, it allows structural investigation, analysis and synthesis of materials, using photon, electron, neutron and ion based techniques. It enables the delivery of innovative solutions to societal challenges in the fields of energy, health, food, cultural heritage and more.

> Find out more
9.6.2020

CERIC-ERIC, the superlaboratory open for scientists all over the world

26.8.2020

The DOI for data

10.6.2020

Nano-analytics for Pharmaceutics: interview with Aden Hodzic

Projects and collaborations